Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiBiogen's tau therapy drives bigger benefits in 2-year Alzheimer's update
MiLess than a year into the job, Everett Cunningham steps down as Quanterix CEO
MiPfizer enters in vivo CAR-T space via 3-program, $2.6B deal with China's Starna
MiClene Nanomedicine uses CRO Veristat's biostatistics platform for FDA submission
MiVertex signs $220M deal with Genomics to re-up long-running discovery pact
MiAt Fierce's London event, Big Pharmas tell biotechs to 'be transparent' to secure deals
MiPriavoid's Alzheimer's pill fails to prove efficacy in phase 2 trial
MiMerck axes $2.7B BTK inhibitor program after seeing phase 3 data
MiFDA clears MiniMed Fit tubeless insulin pump
MiCognito phase 3 flops in light-and-sound Alzheimer's trial, but sees 'signal' for HOPE
DiScientists uncover 'very detailed map' of an enzyme target for rare metabolic disease
DiKyntra axes mid-stage ADC, adding to years of stumbles
DiMedtronic pays $380M-plus for Contego Medical buyout
DiIsomorphic Labs raises $5B series C months after $2.1B round
DiWhy 2027 could be 'Europe's year to shine': Panelists debate biotech funding at Fierce's London event
DiMarrow extracts $120M series B to advance preclinical blood disease therapy
DiSellas marks 9-month survival benefit in late-stage leukemia vaccine study
DiLilly signs $5.9B deal with Stipple to unlock oncology targets
MoHelus' chemically modified psychedelic hits key goals in phase 3 depression trial
MoBiogen inks $411M neurodegeneration pact with protein degrader biotech TrimTech
MoLilly secures another myelofibrosis option via $1.5B deal for JPM-founded Calytrix
MoJ&J pays $2.2B upfront for Ollin to challenge Roche's Vabysmo with phase 3 bispecific
MoBuilding resilient biomanufacturing supply networks
MoAclaris scratches TSLP program from pipeline after flunking phase 2 eczema test
MoFlagship commits £100M to set up AI-focused biotech incubation outpost in London